Ambry Genetics’ CARE Program® Wins 2026 MedTech Breakthrough Award for “Best Overall Health Informatics Solution”

Ambry Genetics’ CARE Program® Wins 2026 MedTech Breakthrough Award for “Best Overall Health Informatics Solution”

Ambry Genetics, a leader in clinical genomic testing, and a wholly owned subsidiary of Tempus AI, Inc. (NASDAQ: TEM),

MedTech Breakthrough Announces Winners of the 10th Annual Awards Program

The 10th annual awards program recognizes the world’s most innovative digital health and medical technology solutions. MedTech Breakthrough, an independent market intelligence organization, has announced the winners of its 10th annual awards program. The program recognizes companies and products in the global health and medical technology market, according to a release from the organization. The 2026 awards program received a record number of no…